Ensign Peak Advisors
TMCI icon

Ensign Peak Advisors’s Treace Medical Concepts TMCI Stock Holding History

Ensign Peak Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,340
Closed -$30K – 2191
2022
Q3 		$30K Buy
1,340
+440
+49% +$8.51K ﹤0.01% 2286
2022
Q2 		$13K Hold
900
– – ﹤0.01% 2141
2022
Q1 		$17K Buy
+900
New +$17.5K ﹤0.01% 2184

Other funds holding TMCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Ensign Peak Advisors's TMCI Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Treace Medical Concepts (TMCI) in Q4 2022, closing a stake of 1,340 shares — an estimated $30K sold.

Ensign Peak Advisors first reported a position in TMCI in Q1 2022 and held it in 3 quarters. The position peaked at $30K in Q3 2022. 106 funds tracked by Wall St. Rank hold TMCI as of Q4 2022.

  • Ensign Peak Advisors reported no remaining Treace Medical Concepts position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 1,340 Treace Medical Concepts shares in Q4 2022, an estimated $30K.
  • Ensign Peak Advisors first reported a position in Treace Medical Concepts in Q1 2022 and held it in 3 quarters.
  • Ensign Peak Advisors's Treace Medical Concepts position peaked at $30K in Q3 2022.
  • 106 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.